Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03816163 |
|---|---|
| Brief Title: | A Study to Assess the Efficacy and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma |
| First Submitted : | January 23, 2019 |
| First Submitted that Met QC Criteria : | January 23, 2019 |
| First Posted : | January 25, 2019 |
| Last Update Submitted that Met QC Criteria : | April 18, 2024 |
| Last Update Posted : | April 19, 2024 |